摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pyrazin-carbonsaeure-(2)-isopropylamid | 90607-36-6

中文名称
——
中文别名
——
英文名称
Pyrazin-carbonsaeure-(2)-isopropylamid
英文别名
pyrazine-2-carboxylic acid isopropylamide;N-propan-2-ylpyrazine-2-carboxamide
Pyrazin-carbonsaeure-(2)-isopropylamid化学式
CAS
90607-36-6
化学式
C8H11N3O
mdl
MFCD01349585
分子量
165.195
InChiKey
DLFPZLKEZOVQNJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.375
  • 拓扑面积:
    54.9
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
    申请人:Berger Richard
    公开号:US20090253705A1
    公开(公告)日:2009-10-08
    The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
    本发明提供了式(I)的化合物,其药物组成物以及使用该化合物在治疗或预防由β3-肾上腺素受体激活介导的疾病的方法。
  • Pyrrolidine amide compounds as histone demethylase inhibitors
    申请人:GENENTECH, INC.
    公开号:US10022354B2
    公开(公告)日:2018-07-17
    The present invention relates to compounds useful as inhibitors of one or more histone demethylases, such as KDM5. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
    本发明涉及可用作一种或多种组蛋白去甲基化酶(如 KDM5)抑制剂的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物,以及使用所述组合物治疗各种疾病的方法。
  • Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US10695328B2
    公开(公告)日:2020-06-30
    The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
    本发明提供了式 (I) 的化合物: 或其立体异构体,或其药学上可接受的盐,其中所有变量如本文所定义。这些化合物是单酰基甘油酰基转移酶 2 型(MGAT2)抑制剂,可用作药物。
  • Synthesis of desosamines
    申请人:President and Fellows of Harvard College
    公开号:US11008358B2
    公开(公告)日:2021-05-18
    The present invention provides desosamine and mycaminose analogs and nitro sugars and methods for their preparation. The invention also provides methods of cyclizing a compound of Formula (A′) with glyoxal to give a nitro sugar of Formula (B). Methods for the preparation of compound of Formula (D′) are provided comprising cyclization of a nitro alcohol to give a nitro sugar and reduction and alkylation of the nitro sugar to give a desosamine, mycaminose, or an analog thereof.
    本发明提供脱糖胺和霉菌胺糖类似物和硝基糖及其制备方法。本发明还提供了式(A′)化合物与乙二醛环化得到式(B)硝基糖的方法。本发明提供了制备式(D′)化合物的方法,包括硝基醇环化得到硝基糖,硝基糖还原和烷基化得到脱糖胺、霉菌胺糖或其类似物。
  • COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR
    申请人:RYDER Sean
    公开号:US20110065704A1
    公开(公告)日:2011-03-17
    The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with parasitic infections and inflammatory disorders.
查看更多